Ian Quigley says Leash Bio's flagship agent task, developed over the preceding couple of months, is a structure-activity relationship problem.

“And so the flagship problem that we spent a lot of time over the past couple months on is a structure activity relationship problem. And the idea there is like, okay, I've got some molecules, and I know that they bind, maybe they bind to this protein that I want them to.”